NRX Pharmaceuticals, Inc. - FORM S-1/A - EX-99.2 - CONSENT OF MICHAEL FONG - November 14, 2017

Attached files

file filename
EX-10.8 - PROMISSORY NOTE, DATED AS OF SEPTEMBER 26, 2017, IN FAVOR OF BIG ROCK PARTNERS S - NRX Pharmaceuticals, Inc.brpa_ex108.htm
EX-99.8 - FORM OF NOMINATING COMMITTEE CHARTER - NRX Pharmaceuticals, Inc.brpa_ex998.htm
EX-99.7 - FORM OF COMPENSATION COMMITTEE CHARTER - NRX Pharmaceuticals, Inc.brpa_ex997.htm
EX-99.6 - FORM OF AUDIT COMMITTEE CHARTER - NRX Pharmaceuticals, Inc.brpa_ex996.htm
EX-99.5 - CONSENT OF TROY T. TAYLOR - NRX Pharmaceuticals, Inc.brpa_ex995.htm
EX-99.4 - CONSENT OF ALBERT G. REX - NRX Pharmaceuticals, Inc.brpa_ex994.htm
EX-99.3 - CONSENT OF STUART KOENIG - NRX Pharmaceuticals, Inc.brpa_ex993.htm
EX-99.1 - CONSENT OF RICHARD BIRDOFF - NRX Pharmaceuticals, Inc.brpa_ex991.htm
EX-23.1 - CONSENT OF MARCUM LLP - NRX Pharmaceuticals, Inc.brpa_ex231.htm
EX-14 - FORM OF CODE OF ETHICS - NRX Pharmaceuticals, Inc.brpa_ex14.htm
EX-10.9 - FORM OF INDEMNIFICATION AGREEMENT FOR OFFICERS, DIRECTORS AND SPECIAL ADVISORS - NRX Pharmaceuticals, Inc.brpa_ex109.htm
EX-10.7 - PROMISSORY NOTE, DATED AS OF SEPTEMBER 26, 2017, IN FAVOR OF RICHARD ACKERMAN - NRX Pharmaceuticals, Inc.brpa_ex107.htm
EX-10.6 - SECURITIES SUBSCRIPTION AGREEMENT, DATED SEPTEMBER 26, 2017, BETWEEN THE REGISTR - NRX Pharmaceuticals, Inc.brpa_ex106.htm
EX-10.5 - FORM OF ADMINISTRATIVE SERVICES AGREEMENT - NRX Pharmaceuticals, Inc.brpa_ex105.htm
EX-10.4 - FORM OF REGISTRATION RIGHTS AGREEMENT AMONG THE REGISTRANT AND THE INITIAL STOCK - NRX Pharmaceuticals, Inc.brpa_ex104.htm
EX-10.3 - FORM OF STOCK ESCROW AGREEMENT BETWEEN THE REGISTRANT, CONTINENTAL STOCK TRANSFE - NRX Pharmaceuticals, Inc.brpa_ex103.htm
EX-10.2 - FORM OF INVESTMENT MANAGEMENT TRUST AGREEMENT BETWEEN CONTINENTAL STOCK TRANSFER - NRX Pharmaceuticals, Inc.brpa_ex102.htm
EX-10.1C - FORM OF LETTER AGREEMENT FOR THE REGISTRANT'S SPONSOR - NRX Pharmaceuticals, Inc.brpa_ex101c.htm
EX-10.1B - FORM OF LETTER AGREEMENT FOR EACH OF THE REGISTRANT'S OTHER OFFICERS AND DIRECTO - NRX Pharmaceuticals, Inc.brpa_ex101b.htm
EX-10.1A - FORM OF LETTER AGREEMENT FOR THE REGISTRANT'S SPONSOR - NRX Pharmaceuticals, Inc.brpa_ex101a.htm
EX-5.1 - OPINION OF AKERMAN LLP - NRX Pharmaceuticals, Inc.brpa_ex51.htm
EX-4.7 - FORM OF UNIT PURCHASE OPTION - NRX Pharmaceuticals, Inc.brpa_ex47.htm
EX-4.6 - FORM OF WARRANT AGREEMENT BETWEEN CONTINENTAL STOCK TRANSFER & TRUST COMPANY AND - NRX Pharmaceuticals, Inc.brpa_ex46.htm
EX-4.5 - FORM OF RIGHT AGREEMENT BETWEEN CONTINENTAL STOCK TRANSFER & TRUST COMPANY AND R - NRX Pharmaceuticals, Inc.brpa_ex45.htm
EX-4.4 - SPECIMEN WARRANT CERTIFICATE - NRX Pharmaceuticals, Inc.brpa_ex44.htm
EX-4.3 - SPECIMEN RIGHT CERTIFICATE - NRX Pharmaceuticals, Inc.brpa_ex43.htm
EX-4.2 - SPECIMEN COMMON STOCK CERTIFICATE - NRX Pharmaceuticals, Inc.brpa_ex42.htm
EX-4.1 - SPECIMEN UNIT CERTIFICATE - NRX Pharmaceuticals, Inc.brpa_ex41.htm
EX-3.4 - ARTICLES OF INCORPORATION / BYLAWS - NRX Pharmaceuticals, Inc.brpa_ex34.htm
EX-3.2 - FORM OF AMENDED AND RESTATED CERTIFICATE OF INCORPORATION - NRX Pharmaceuticals, Inc.brpa_ex32.htm
EX-1.2 - LETTER AGREEMENT BETWEEN THE REGISTRANT AND EARLYBIRDCAPITAL - NRX Pharmaceuticals, Inc.brpa_ex12.htm
EX-1.1 - UNDERWRITING AGREEMENT - NRX Pharmaceuticals, Inc.brpa_ex11.htm
S-1/A - REGISTRATION STATEMENT AMENDMENT NO. 1 - NRX Pharmaceuticals, Inc.brpa_s1a.htm
 
Exhibit 99.2
 
Consent of Director Nominee
 
Big Rock Partners Acquisition Corp.
 
Pursuant to Rule 438 of Regulation C promulgated under the Securities Act of 1933, as amended (the “Securities Act”), in connection with the Registration Statement on Form S-1 (the “Registration Statement”) of Big Rock Partners Acquisition Corp. (the “Company”), the undersigned hereby consents to being named and described as a director nominee in the Registration Statement and any amendment or supplement to any prospectus included in such Registration Statement, any amendment to such Registration Statement or any subsequent Registration Statement filed pursuant to Rule 462(b) under the Securities Act and to the filing or attachment of this consent with such Registration Statement and any amendment or supplement thereto.
 
IN WITNESS WHEREOF, the undersigned has executed this consent as of November 14, 2017.
 
 
/s/ Michael Fong
 
 
Name: Michael Fong
 
 
 
 
 

NRX Pharmaceuticals, Inc. Reports